Owkin, the first end-to-end AI-biotech that uses cutting-edge causal AI to unlock precision drug discovery, development and ...

Owkin has partnered with AstraZeneca to develop an AI gBRCA pre-screen solution for breast cancer. Takeaway Points Owkin has ...

The solution will use Owkin's data network and artificial intelligence to pre-screen for gBRCA mutations in breast cancer directly from digital pathology slides.

EOT.AI, a leader in AI-powered solutions for industrial enterprises, has announced the upcoming release of its innovative ...

Alfa Laval will release third quarter earnings on 24 October at 07:30 am CET. The conference call will start at 09:00 am CET. The conference call is hosted by Alfa Laval's President and CEO Tom Erixon ...

Fractus, a leader in in antenna technology and IP licensing, announced today the successful signing of a patent licensing agreement with ADT, the market leader in connected alarm systems in the United ...

Owkin has enticed another big pharma partner with its artificial intelligence-powered clinical development platform, Bristol-Myers Squibb, which is paying $80 million upfront to tap into its ...

The Penticton public is welcome to join the Okanagan Nation Alliance for a Walk for Reconciliation Monday morning.

One of the biggest market access stories this year has been the launch of Lilly Direct (and, subsequently, PfizerForAll .) ...

"The National Day for Truth and Reconciliation and Orange Shirt Day is an important opportunity to show allyship, honour ...